A new and frequent human T-cell leukemia virus indeterminate western blot pattern: Epidemiological determinants and PCR results in Central African inhabitants

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1663-1672

  Filippone, Claudia ^a   Bassot, Sylviane ^a   Betsem, Edouard ^a,b   Tortevoye, Patricia ^a   Guillotte, Micheline ^a   Mercereau Puijalon, Odile ^a   Plancoulaine, Sabine ^a,c   Calattini, Sara ^a   Gessain, Antoine ^a  

^a INSTITUT PASTEUR   (France)

^b Universite de Yaounde I Faculte de Medecine   (Cameroon)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CENTRAL AFRICA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HTLV 1 GAG INTERMEDIATE PATTERN; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 3; HUMAN T CELL LEUKEMIA VIRUS 4; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AFRICA, CENTRAL; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; LEUKEMIA, T-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84860004535     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06540-11     Document Type: Article

References (75)

1. Abrams A, Akahata Y, Jacobson S. 2011. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns. Viruses 3:1320-1331.
2. Altamirano NA, Rocco C, Aulicino P, Sen L, Mangano A. 2010. Quantitation of HTLV-I proviral load by a real-time PCR assay using SYBR Green: comparison of two methods for DNA isolation. J. Virol. Methods 170:160-164.
3. Andersson S, et al. 1999. Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa. Transfusion 39:845-851. (Pubitemid 30452049)
4. Andrade RG, et al. 2010. Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors. Rev. Soc. Bras. Med. Trop. 43(2):111-115.
5. Arjmand B, et al. 2009. Seroprevalence of human T lymphotropic virus (HTLV) among tissue donors in Iranian tissue bank. Cell Tissue Bank 10:247-252.
6. Berini CA, Eirin ME, Pando MA, Biglione MM. 2007. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina. J. Med. Virol. 79:69-73. (Pubitemid 44902056)
7. Berini CA, et al. 2008. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2. J. Virol. Methods 147:322-327.
8. Besson G, Kazanji M. 2009. One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, 3. J. Clin. Microbiol. 47:1129-1135.
9. Betsem E, Rua R, Tortevoye P, Froment A, Gessain A. 2011. Frequent and recent human acquisition of simian foamy viruses through apes bites in Central Africa. PLoS Pathog. 7:e1002306.
10. Busch MP, et al. 1994. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood 83:1143-1148. (Pubitemid 24058567)
11. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. 2000. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 40:443-449. (Pubitemid 30230509)
12. Calattini S, et al. 2009. New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results. J. Infect. Dis. 199:561-564.
13. Calattini S, et al. 2005. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2:30.
14. Cassar O, et al. 2007. Human T lymphotropic virus type 1 subtype C Melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor. J. Infect. Dis. 196:510-521. (Pubitemid 47206096)
15. Caterino-de-Araujo A, et al. 1998. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to Western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil. Diagn. Microbiol. Infect. Dis. 30:173-182.
16. Caterino-de-Araujo A. 2009. Best screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2 in South America. J. Virol. Methods 156:150-151.
17. Césaire R, et al. 1999. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion 39:1145-1149. (Pubitemid 29485333)
18. Chandia L, et al. 2010. Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile. Med. Microbiol. Immunol. 199:341-344.
19. Cohen RS, Xiong SC, Sakamoto P. 2010. Retrospective study of serological testing of potential human milk donors. Arch. Dis. Child Fetal Neonatal Ed. 95:F118-F120.
20. Costa EAS, Magri MC, Caterino-de-Araujo A. 2011 The best algorithm to confirm the diagnosis of HTLV-1 and HTLV-2 in at-risk individuals from São Paulo, Brazil. J. Virol. Methods 173:280-286.
21. Defer C, et al. 1995. Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T-lymphotropic virus infection in French blood donors. Retrovirus Study Group of the French Society of Blood Transfusion. Transfusion 35:596-600.
22. Delmonico F, Snydman DR. 1998. Organ donor screening for infectious diseases: review of practice and implications for transplantations. Transplantation 65:603-610. (Pubitemid 28128926)
23. Gallo D, Penning LM, Hanson CV. 1991. Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method. J. Clin. Microbiol. 29:2345-2347.
24. Garin B, Gosselin S, de Thé GG, Gessain A. 1994. HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate Western blot pattern. J. Med. Virol. 44:104-109. (Pubitemid 24288134)
25. Gessain A, Dezzutti CS, Cowan EP, Lal RB. Human T-cell lymphotropic virus types 1 and 2, p 1330-1339. In Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
26. Gessain A, et al. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410. (Pubitemid 15231248)
27. Gessain A, et al. 1995. Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc. Natl. Acad. Sci. U. S. A. 92:4041-4045.
28. Gessain A, Mahieux R, de Thé G. 1995. HTLV-I " indeterminate" Western blot patterns in sera from tropical regions: the situation revisited. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8:315-318.
29. Gessain A, Hollsberg PP, Hafler DA. 1996. Epidemiology of HTLV-I and associated diseases, p 34-64. In Hollsberg P, Hafler DA (ed), Human T-cell lymphotropic virus I. John Wiley and Sons, New York, NY.
30. Hadlock KG, et al. 1995. Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein. Blood 86:1392-1399.
31. Hayes CG, Burans JP, Oberst RB. 1991. Antibodies to human T lymphotropic virus type I in a population from the Philippines: evidence for cross-reactivity with Plasmodium falciparum. J. Infect. Dis. 163:257-262.
32. Hinuma Y, et al. 1982. Antibodies to adult T-cell leukemia-virus- associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide sero-epidemiologic study. Int. J. Cancer 29:631-635. (Pubitemid 12089201)
33. Ikeda M, et al. 1984. A new agglutination test for serum antibodies to adult T-cell leukemia virus. Gann. 75:845-848. (Pubitemid 15216258)
34. Ishak R, et al. 2007. Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies. Epidemiol. Infect. 135:604-609. (Pubitemid 46647398)
35. Jacob F, Santos-Fortuna EL, Azevedo RS, Caterino-de-Araujo A. 2007. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil. Rev. Inst. Med. Trop. Sao Paulo. 49:361-364.
36. Khameneh ZR, Sepehrvand N, Masudi S, Taghizade-Afshari A. 2010. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp. Clin. Transplant. 8:146-149.
37. Lairmore, MD, Franchini G. 2007. Human T-cell leukemia virus types 1 and 2. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
38. Lipka JJ, et al. 1990. Determination of a unique immunodominant epitope of HTLV-I. Infect. Dis. 162:353-357.
39. Lipka JJ, et al. 1991. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II. J. Infect. Dis. 164:400-403.
40. Lipka JJ, et al. 1991. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang. 61:171-176.
41. Mahieux R, et al. 2000. Human T-cell lymphotropic virus type 1 Gag indeterminate Western blot patterns in Central Africa: relationship to Plasmodium falciparum infection. J. Clin. Microbiol. 38:4049-4057. (Pubitemid 32233204)
42. Mahieux R, Gessain A. 2011. HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology, and molecular aspects. Viruses 3:1074-1090.
43. Malm K, Kjerstadius TT, Andersson S. 2010. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use. J. Med. Virol. 82:1606-1611.
44. Mangano AM, Remesar M, del Pozo A, Sen L. 2004. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns. J. Med. Virol. 74:323-327. (Pubitemid 39150400)
45. Manns A, et al. 1991. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients. Blood 77:896-905.
46. Martins ML, et al. 2010. Long-term serological follow-up of blood donors with an HTLV-indeterminate Western blot: antibody profile of seroconverters and individuals with false reactions. J. Med. Virol. 82:1746-1753.
47. Mauclère P, et al. 1997. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa. J. Infect. Dis. 176:505-509. (Pubitemid 27328776)
48. Mauclère P, et al. 2011. HTLV-2 strains, similar to those found in several Amerindian tribes, are endemic in central African Bakola Pygmies. J. Infect. Dis. 203:1316-1323.
49. Meertens L, et al. 2001. Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology 287:275-285. (Pubitemid 32804014)
50. Morimoto HK, et al. 2007. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Rev. Inst. Med. Trop. S. Paulo. 49:225-230. (Pubitemid 47403206)
51. Nowicki MJ, et al. 2006. High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testing. Transplantation 82:1210-1213. (Pubitemid 44748024)
52. Olah I, et al. 2010. Neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate HTLV Western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals. J. Med. Virol. 82:837-842.
53. Poiesz BJ, et al. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. 77:7415-7419. (Pubitemid 11131140)
54. Porter KR, et al. 1994. Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya, Indonesia. Clin. Diagn. Lab Immunol. 1:11-15. (Pubitemid 2036264)
55. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058-6068. (Pubitemid 43086123)
56. Roucoux DF, Murphy EL. 2004. The epidemiology and disease outcomes of human T-lymphotropic virus type-II. AIDS Rev. 6:144-154. (Pubitemid 39599984)
57. Rouet F, et al. 2001. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean. J. Clin. Microbiol. 39:1247-1253. (Pubitemid 32275415)
58. Ruff AJ. 1994. Breastmilk, breastfeeding, and transmission of viruses to the neonate. Semin. Perinatol. 18:510-516.
59. Sabino EC, et al. 1999. Evaluation of the INNO-LIA HTLV I/II assay for confirmation of human T-cell leukemia virus - reactive sera in blood bank donations. J. Clin. Microbiol. 37:1324-1328. (Pubitemid 29187792)
60. Sintasath DM, et al. 2009. Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey. Retrovirology 6:97.
61. Soares BC, Proietti AB, Proietti FA. 2003. Interdisciplinary HTLV-I/II Research Group. HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population. Rev. Saude Publica 37:470-476. (Pubitemid 37173380)
62. Switzer WM, et al. 2009. Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4. Retrovirology 6:9.
63. Thorstensson R, Albert J, Andersson S. 2002. Strategies for diagnosis of HTLV-I and -II. Transfusion 42:780-791.
64. Varma M, et al. 1995. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by Western blot (immunoblot) assay containing recombinant envelope glycoproteins. J. Clin. Microbiol. 33:3239-3244.
65. Verdonck K, González E, Van Dooren S, Vandamme AM, and Vanham G, Gotuzzo E. 2007. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 7:266-281. (Pubitemid 46414075)
66. Verdonck K, et al. 2009. Comparison of three ELISAs for the routine diagnosis of human T-lymphotropic virus infection in a high-prevalence setting in Peru. Trans. R. Soc. Trop. Med. Hyg. 103:420-422.
67. Vrielink H, et al. 1999. Comparison of four HTLV-I and HTLV-II + II ELISAs. Vox Sang. 76:187-191. (Pubitemid 29204535)
68. Waters A, et al. 2011. Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results. J. Clin. Virol. 52:38-44.
69. Waziri A, Soldan SS, Graf MD, Nagle J, Jacobson S. 2000. Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from a HTLV-1/2 seroindeterminate patient. J. Virol. 74:2178-2185. (Pubitemid 30091471)
70. Weiss RA. 1993. Milk-borne transmission of HTLV-1. Jpn. J. Cancer Res. 84:inside front cover.
71. Wiktor SZ, et al. 1990. Distinguishing between HTLV-I and HTLV-II by Western blot. Lancet 335:1533. (Pubitemid 20224952)
72. Wolfe ND, et al. 2005. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc. Natl. Acad. Sci. U. S. A. 102:7994-7999. (Pubitemid 40781051)
73. Yao K, et al. 2006. Human T lymphotropic virus types I and II Western blot seroindeterminate status and its association with exposure to prototype HTLV-1. J. Infect. Dis. 193:427-437. (Pubitemid 43122343)
74. Zanjani DS, et al. 2011. Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env and gag sequences. AIDS Res. Hum. Retroviruses 27:131-135.
75. Zheng H, et al. 2010. Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon. Virology 401:137-145.